Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
New Ray Medicine International Holding Ltd. ( (HK:6108) ) has provided an announcement.
New Ray Medicine International Holding Ltd. successfully passed all resolutions at its Annual General Meeting held on June 18, 2025. Key resolutions included the re-election of directors, approval of financial statements, and granting of mandates for share repurchase and issuance. The unanimous approval of these resolutions, with nearly 100% of votes in favor, reflects strong shareholder support and positions the company for continued strategic growth and governance improvements.
More about New Ray Medicine International Holding Ltd.
New Ray Medicine International Holding Ltd. is a company incorporated in Bermuda with limited liability, operating in the pharmaceutical industry. It focuses on the distribution and marketing of pharmaceutical products, primarily targeting the Asian market.
Average Trading Volume: 3,644,173
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$60.19M
See more data about 6108 stock on TipRanks’ Stock Analysis page.